Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
UW Hindbrain Malformation Research Program, |
RCV000201755 | SCV000256385 | pathogenic | Joubert syndrome 5 | 2015-02-23 | criteria provided, single submitter | research | |
Invitae | RCV000685655 | SCV000813143 | pathogenic | Joubert syndrome; Meckel-Gruber syndrome; Nephronophthisis | 2018-09-24 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Gln662*) in the CEP290 gene. It is expected to result in an absent or disrupted protein product. This variant is not present in population databases (ExAC no frequency). This variant has been observed in combination with another CEP290 variant in individuals affected with Joubert syndrome (PMID: 26092869) and has been observed in individuals affected with CEP290-related conditions (PMID: 17564974, 23188109, 23351400, 19466712). ClinVar contains an entry for this variant (Variation ID: 56733). Loss-of-function variants in CEP290 are known to be pathogenic (PMID: 16909394, 17345604, 20690115). For these reasons, this variant has been classified as Pathogenic. |
Juha Muilu Group; Institute for Molecular Medicine Finland |
RCV000050146 | SCV000082556 | probable-pathogenic | Meckel syndrome, type 4 | no assertion criteria provided | not provided | Converted during submission to Likely pathogenic. | |
Medical Genetics Laboratory, |
RCV000787559 | SCV000926535 | pathogenic | Leber congenital amaurosis | 2018-04-01 | no assertion criteria provided | research | |
Medical Genetics Laboratory, |
RCV000787812 | SCV000926822 | pathogenic | Retinitis pigmentosa | 2018-04-01 | no assertion criteria provided | research | |
Natera, |
RCV000787559 | SCV001457920 | pathogenic | Leber congenital amaurosis | 2020-09-16 | no assertion criteria provided | clinical testing |